TOTAL: $336.25M | ||||
Company (Symbol)# | Type Of Financing |
Number Of Shares, Units Or Warrants (M) | Amount Raised ($M)* |
Investors; Placement Agents; Details (Date)@ |
Abgenix Inc. (ABGX) | Private placement of common stock | 1.8S | $75 |
Abgenix sold 1.8M shares of common stock to selected institutional and other accredited investors at $42 per share; Pacific Growth Equities served as placement agent (11/15) |
Avigen Inc. (AVGN) |
Private placement of common stock and warrants |
ND | $40 | Avigen sold an undisclosed amount of common stock and warrants to a group of investors from the United States and Europe; the investor group purchased shares of the common stock in multiple closings at per-share purchase prices equal to the closing prices on the Nasdaq National Market on the respective days of closing; for every five shares purchased, each investor also receives a five-year warrant to purchase one share of common stock at a 25 percent premium to the respective closing price (11/16) |
Aviron (AVIR) |
Private placement of common stock | 0.4MS |
$6E |
Aviron sold 0.4M shares of its common stock to an undisclosed financial institution; further details ND (11/18) |
Axonyx Inc. (OTC BB:AXYX) | Private placement of common stock and warrants |
170 units of 0.004S and 0.002W | $4.25 | Axonyx sold 170 units at $0.025M to an undisclosed investor; each unit consists of 0.004M shares of restricted common stock and 0.002M five-year warrants, exercisable at $11.00 (11/2) |
Cell Therapeutics Inc. (CTIC) |
Private placement of convertible preferred stock | ND |
$10 |
Cell Therapeutics sold $10M of its Series A convertible preferred stock, convertible to 4.6M shares of common stock; in connection with the financing, the company issued warrants to the investor group to purchase 1.4M shares of common stock at $2.87 per share; lead investor was Essex Woodlands Health Ventures Fund (11/16) |
Digene Corp. (DIGE) |
Private placement of common stock |
1.5S | $19.5 |
Digene and certain of its stockholders entered into definitive agreements for the private placement of an aggregate of 1.5M shares of common stock to selected institutional and other accredited investors; 0.9M shares will be sold by the company, and 0.6M shares will be sold by the selling stockholders, all at $13 per share (11/19) |
Epoch Pharmaceuticals Inc. (OTC BB:EPPH.OB) | Private placement of stock | ND | $3 | Epoch raised $3M in a private financing at a price of $2.50 per share; investors included PE Corp., Bay City Capital, Grace Brothers Ltd. and Hilspen Capital Management; further details ND (11/3) |
The Immune Response Corp. (IMNR) | Private placement of common stock | 0.8S |
$3.1 | Immune Response sold 0.8M shares of common stock to an institutional investor at $4 per share, a 6 percent discount to the average of the weighted average trading price of the company's common stock during the 20-trading-day period ended 11/18 (11/23) |
Matritech Inc. (NMPS) |
Private placement of units |
0.9 units of 2S and 1W |
$3.6 |
Undisclosed private investors invested $3.6M in the company through a private placement of 0.9M units at a price of $4 per unit; each unit consisted of two shares of common stock and a warrant to purchase one share of common stock; the warrants are exercisable at $2.20 per share for a period of two years and are callable by Matritech if certain common stock price levels are reached during the two-year period (11/18) |
Maxim Pharmaceuticals Inc. (AMEX:MMP) |
Private placement of convertible preferred stock |
ND | $20.6 | Maxim placed $20.6M of convertible preferred stock with a group of existing shareholders and new investors based in the U.S. and Europe; the preferred stock is convertible into shares of common stock at a fixed price of $8.90 per share, based on the average closing bid prices for the five days prior to completion of the placement; the preferred stock may be converted into a total of 2.3M shares of common stock (11/2) |
NeoTherapeutics Inc. (NEOT) |
Private placement of common stock | 0.8S | $10 | NeoTherapeutics sold 0.8M shares of common stock to two institutional investors at $11.83 per share; in addition, the investors received five-year warrants to purchase 0.13M shares of common stock at an exercise price of $14.24 per share, and additional adjustment warrants to purchase additional shares of common stock at two reset dates, four and six months subsequent to the closing (11/19) |
Neurobiological Technologies Inc. (OTC BB:NTII) | Private placement of securities |
Units of 5S stock and 1W | $4.2 | Neurobiological raised $4.2M in gross proceeds from a private placement of its securities at $4 per unit; each unit consisted of five shares of common stock and a five-year warrant to purchase two shares of common stock exercisable at $1.75 per share; placement agent was AmeriCal Securities Inc.; existing and new investors included Paramount Capital Inc., Clarion Capital Corp. and Active Site Partners (11/11) |
Nexell Therapeutics Inc. (NEXL) | Private placement of convertible preferred stock | 0.063S |
$63 | Nexell raised $63M in a private placement of Series B preferred stock, convertible into common stock at $2.75 per share; Lehman Brothers acted as placement agent; investors included John Hancock Mutual Life Insurance Co., Metropolitan Life Insurance Co. and Massachusetts Mutual Life Insurance Co. (11/29) |
Nymox Pharmaceutical Corp. (NYMX) |
Private placement of common stock |
ND | $12 |
Nymox raised $12M in a private placement of common stock to institutional investors; Ladenburg Thalmann & Co. acted as placement agent (11/12) |
Procyon Biopharma Inc. (Canada; ASE:PBP) |
Private placement of common stock | 12S | $2 | Procyon completed the second phase of a private financing, the first phase of which was completed in October; the company issued 12M shares of common stock at $0.25 per share to European and other investors, and to T2C2 and Innovatech du Grand Montreal, Quebec-based venture capital firms (11/22) |
Notes: | ||||
@ The dates listed indicate the issue dates of press releases, and are not necessarily the dates on which stated events took place. | ||||
* Conversion rate of C$1 3D US$0.68; ND 3D Information not disclosed. | ||||
# Unless otherwise indicated, the stock symbols listed are on the Nasdaq Market. | ||||
AMEX 3D American Stock Exchange, ASE 3D Alberta Stock Exchange, OTC BB 3D Over-the-Counter Bulletin Board |